Chemoinformaics analysis of 2,6,10,14,18,22-Tetracosahexaene
Molecular Weight | 326.568 | nRot | 15 |
Heavy Atom Molecular Weight | 288.264 | nRig | 6 |
Exact Molecular Weight | 326.297 | nRing | 0 |
Solubility: LogS | -6.926 | nHRing | 0 |
Solubility: LogP | 8.543 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 62 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 38 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 24 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 65.4181 |
nHD | 0 | BPOL | 38.1219 |
QED | 0.21 |
Synth | 2.849 |
Natural Product Likeliness | 0.62 |
NR-PPAR-gamma | 0.506 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.92 |
HIA | 0.005 |
CACO-2 | -4.533 |
MDCK | 0.00000702 |
BBB | 0.133 |
PPB | 0.942508 |
VDSS | 3.284 |
FU | 0.020886 |
CYP1A2-inh | 0.977 |
CYP1A2-sub | 0.126 |
CYP2c19-inh | 0.413 |
CYP2c19-sub | 0.055 |
CYP2c9-inh | 0.838 |
CYP2c9-sub | 0.947 |
CYP2d6-inh | 0.177 |
CYP2d6-sub | 0.72 |
CYP3a4-inh | 0.635 |
CYP3a4-sub | 0.051 |
CL | 11.378 |
T12 | 0.049 |
hERG | 0.002 |
Ames | 0.029 |
ROA | 0 |
SkinSen | 0.991 |
Carcinogencity | 0.263 |
EI | 0.99 |
Respiratory | 0.007 |
NR-Aromatase | 0.83 |
Antiviral | No |
Prediction | 0.628656 |